Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI (RENX.L,RNLX), and partner Bio-Techne Corp. (TECH), have received CE marking for COVID-SeroKlir and COVID-SeroIndex, Kantaro's quantitative SARS-CoV-2 IgG antibody test kits. COVID-SeroKlir is configured to be most useful in a clinical setting. COVID-SeroIndex configuration is anticipated to be used for research purposes or vaccine development. Both test kits are available immediately and can be used by any authorized clinical testing laboratory in the European Union.
Chuck Kummeth, Bio-Techne's CEO, said: "We are prepared to produce up to 10 million tests per month and ready to support any further rapid expansion."
For comments and feedback contact: editorial@rttnews.com
Business News
January 30, 2026 15:51 ET The Federal Reserve policy decision was the main event in the final week of January, which saw a heavy flow of economics news. Several data reflecting the trends in the U.S. economy were also released during the week. The interest rate decision from Canada also was in focus. In Europe, economic sentiment data gained attention. The policy decision from Singapore was the highlight in Asia.